ACTG1 and colon adenocarcinoma: Ming et al. found that the expression of ACTG1 was considerably upregulated in colon adenocarcinoma based on genome-scale CRISPR-Cas9 knockout (GeCKO) screening and TCGA-COAD data121, which is consistent with the results of our bioinformatics research.